Takeda · Launch Intelligence

Portfolio cockpit

Six assets, six metrics, every figure sourced from public data.

Portfolio readiness
77/100
mean of 6 assets
Strongest asset
88
+2ptsFruzaqla
Watch list
58
+2ptsMezagitamab
Next milestone
Q4 2026
OveporextonFirstLight topline readout

Fruzaqla

Launched
Fruquintinib · Metastatic colorectal cancer (3L+)
88
+2 pts MoMNov 2023 (US), 2024 (EU/JP)
Regulatory 95
Trial momentum 70
Evidence 82
Access / HTA 84
Digital momentum 71
Competitive 74

Adzynma

Launched
ADAMTS13 recombinant · Congenital thrombotic thrombocytopenic purpura
86
+2 pts MoMNov 2023 (US), 2024 (EU)
Regulatory 94
Trial momentum 62
Evidence 68
Access / HTA 79
Digital momentum 52
Competitive 90

Eohilia

Launched
Budesonide oral suspension · Eosinophilic esophagitis
83
+1 pts MoMFeb 2024 (US)
Regulatory 92
Trial momentum 64
Evidence 71
Access / HTA 72
Digital momentum 79
Competitive 81

Oveporexton

Pre-launch
TAK-861 · Narcolepsy type 1
78
+4 pts MoMH2 2027 (expected)
Regulatory 84
Trial momentum 82
Evidence 76
Access / HTA 55
Digital momentum 81
Competitive 88

Rusfertide

Pre-launch
Rusfertide (Protagonist-partnered) · Polycythemia vera
71
+2 pts MoM2027-2028 (expected)
Regulatory 68
Trial momentum 79
Evidence 74
Access / HTA 48
Digital momentum 58
Competitive 72

Mezagitamab

Pre-launch
TAK-079 · Immune thrombocytopenia / IgA nephropathy
58
+2 pts MoM2028 (expected)
Regulatory 55
Trial momentum 66
Evidence 61
Access / HTA 38
Digital momentum 49
Competitive 63

Metric matrix / 100

Every score computed from public-source facts. Hover an asset card for formulas.

AssetRegulatoryTrial momentumEvidenceAccess / HTADigital momentumCompetitiveReadiness
Fruzaqla
Metastatic colorectal cancer (3L+)
95708284717488
Adzynma
Congenital thrombotic thrombocytopenic purpura
94626879529086
Eohilia
Eosinophilic esophagitis
92647172798183
Oveporexton
Narcolepsy type 1
84827655818878
Rusfertide
Polycythemia vera
68797448587271
Mezagitamab
Immune thrombocytopenia / IgA nephropathy
55666138496358

Readiness ranking

Pre-launch Launched

Digital momentum ranking

Composite of search, KOL SoV, news velocity, community, payer chatter